Literature DB >> 34846620

Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.

Meral Torun Bayram1, Cihan Heybeli2, Gizem Yıldız3, Alper Soylu3, Ali Celik2, Sülen Sarioglu4, Salih Kavukçu3.   

Abstract

PURPOSE: To compare clinical, pathological, and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis (HSPN) and IgA nephropathy (IgAN).
METHODS: The medical records of patients diagnosed as HSPN and IgAN during childhood were evaluated retrospectively. HSPN and IgAN groups were compared in terms of gender, age, upper respiratory infection history, blood pressure; presence of nephrotic and/or nephritic syndrome; hemoglobin level, leukocyte count, C-reactive protein (CRP), serum albumin (sAlb), creatinine, complement 3 (sC3), complement 4 (sC4) and immunoglobulin A (sIgA) levels; estimated glomerular filtration rate (eGFR) and proteinuria levels; and renal pathology findings at the onset of disease; total follow-up time; and blood pressure, eGFR and proteinuria levels at the last visit.
RESULTS: Fifty-four patients were enrolled in the study [38 (70%) HSPN and 16 (30%) IgAN]. The median follow-up time was 60.5 and 72.0 months in HSPN and IgAN groups, respectively (p > 0.05). The HSPN and IgAN groups were also not different in terms of gender, age at the onset; leukocyte count, eGFR, sC3-sC4-sIgA levels; and the presence of endocapillary, extracapillary and mesangial proliferation, tubular atrophy, interstitial fibrosis and IgA, IgM, C3 accumulation in renal tissue. Upper respiratory tract infection history was more common in children with IgAN (8/16 vs 8/38, p = 0.045). sAlb (3.96 ± 0.58 vs 4.40 ± 0.46 g/dL, p = 0.005), hemoglobin (12.1 ± 1.3 vs 13.3 ± 1.2 g/dL, p = 0.004,) and the incidence of mesangial IgG deposition (15/38 vs 11/16, p = 0.049) were lower, while CRP (16.3 ± 7.2 vs 7.8 ± 4.4 mg/L, p = 0.002) and proteinuria (72.1 ± 92.4 vs 34.2 ± 37.9 mg/m2/24 h, p = 0.041) was higher in HSPN group at the onset of disease. Proteinuria and eGFR were similar between the two groups at last visit.
CONCLUSION: Children with HSPN and IgAN have little clinical and histological differences in our population. The most prominent difference at presentation with nephritis was higher proteinuria in HSPN probably associated with inflammation due to systemic vasculitis. Long-term renal outcome was good in both HSPN and IgAN.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Children; Henoch–Schonlein purpura nephritis; IgA nephropathy

Mesh:

Substances:

Year:  2021        PMID: 34846620     DOI: 10.1007/s11255-021-03063-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  52 in total

Review 1.  Pediatric IgA nephropathies: clinical aspects and therapeutic approaches.

Authors:  Noel M Delos Santos; Robert J Wyatt
Journal:  Semin Nephrol       Date:  2004-05       Impact factor: 5.299

2.  Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature.

Authors:  Sandra Trapani; Annalisa Micheli; Francesca Grisolia; Massimo Resti; Elena Chiappini; Fernanda Falcini; Maurizio De Martino
Journal:  Semin Arthritis Rheum       Date:  2005-12       Impact factor: 5.532

3.  Clinical outcome in children with Henoch-Schönlein nephritis.

Authors:  Sevgi Mir; Onder Yavascan; Fatma Mutlubas; Betul Yeniay; Ferah Sonmez
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

4.  Henoch-Schönlein purpura in children from western Turkey: a retrospective analysis of 430 cases.

Authors:  Murat Anil; Nejat Aksu; Orhan Deniz Kara; Alkan Bal; Ayşe Berna Anil; Onder Yavaşcan; Binnur Un
Journal:  Turk J Pediatr       Date:  2009 Sep-Oct       Impact factor: 0.552

5.  Renal manifestations in Henoch-Schönlein purpura: a 10-year clinical study.

Authors:  Wen-Liang Chang; Yao-Hsu Yang; Li-Chieh Wang; Yu-Tsan Lin; Bor-Luen Chiang
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

6.  Henoch-Schönlein purpura: a long-term prospective study in Greek children.

Authors:  Andrew Fretzayas; Irini Sionti; Maria Moustaki; Anastasios Papadimitriou; Polyxeni Nicolaidou
Journal:  J Clin Rheumatol       Date:  2008-12       Impact factor: 3.517

Review 7.  IgA nephropathy and Henoch-Schönlein purpura nephritis.

Authors:  John T Sanders; Robert J Wyatt
Journal:  Curr Opin Pediatr       Date:  2008-04       Impact factor: 2.856

8.  Long-term follow-up of childhood Henoch-Schönlein nephritis.

Authors:  A R Goldstein; R H White; R Akuse; C Chantler
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321

9.  Outcome of Henoch-Schönlein purpura nephritis treated with long-term immunosuppression.

Authors:  Mohan Shenoy; Mark G Bradbury; Malcolm A Lewis; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2007-07-24       Impact factor: 3.714

Review 10.  Long-term outcome of Schönlein-Henoch nephritis in the adult.

Authors:  G B Fogazzi; S Pasquali; M Moriggi; S Casanova; I Damilano; M J Mihatsch; P Zucchelli; C Ponticelli
Journal:  Clin Nephrol       Date:  1989-02       Impact factor: 0.975

View more
  1 in total

1.  Urinary complement proteins are increased in children with IgA vasculitis (Henoch-Schönlein purpura) nephritis.

Authors:  Rachael D Wright; Julien Marro; Sarah J Northey; Rachel Corkhill; Michael W Beresford; Louise Oni
Journal:  Pediatr Nephrol       Date:  2022-10-13       Impact factor: 3.651

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.